Tectonic Therapeutic, Inc. Share Price & Technical Analysis

TECX · $29.12 (+2.10%)

Healthcare / Biotechnology

AI Score 64 · Neutral

$29.12

+2.10%

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXF

Price chart

Seasonality

May has 5 positive and 0 negative years (last 5 years shown)

4% return in May, 12% avg return in past 3 year May month.

42% return in 2026, 75% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-5%18%36%-10%4%42%
2516%-53%-31%17%2%-7%13%17%-19%17%18%-2%-10%
24-10%5%-1%-7%23%-7%8%8%58%34%21%-6%127%
2328%54%-28%2%11%-13%63%0%-1%3%-16%4%108%
22-50%-25%-10%-30%6%-5%-1%5%-32%4%33%-22%-128%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 64/100

Neutral · Strong · Uptrend

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$509.47M

P/E ratio

52W high

$36.03

52W low

$14.39

Volume

1,09,612

Related stocks in Healthcare

Frequently asked questions

What is Tectonic Therapeutic, Inc. share price today?
Tectonic Therapeutic, Inc. (TECX) last traded around $29.12 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does TECX have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TECX. Download the app for real-time alerts.
How can I analyze Tectonic Therapeutic, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro